- Your Heart
- Ask Dr. T
- Heart Healthy Living
- About Us
- Contact Us
APEX-AMI trial Analysis
Although 40-65% of patients admitted for treatment of an acute heart attack with percutaneous coronary intervention (PCI) have multiple blockages, current guidelines strongly suggest to limit the procedure to the blocked artery (the culprit vessel).
PCI in “Non-culprit coronary arteries” is associated with a significantly increased risk of dying, as Armstrong and colleagues of the APEX-AMI trial recently published in the European Heart Journal of June, 2010.
The investigators analyzed data from the earlier APEX-AMI trial, which took place in several centers around the world. Among the 5373 patients who underwent primary PCI, 2201 (41%) had multivessel coronary artery disease.
Patients with single-vessel disease only underwent culprit-artery PCI, and had a lower 90-day mortality than patients with multivessel disease (3.1% vs. 6.3%, p<0.001).
Of the patients with multi-vessel disease, most (>90%) just underwent PCI to the culprit vessel, but in 10% of cases other diseased coronary arteries were also stented. As the curves suggest, adverse outcomes became only apparent well after discharge following the intervention:
Kaplan–Meier curve of 90-day mortality in patients with non-IRA PCI vs. IRA-only PCI. (IRA=Infarct related Artery)
Despite this, non-culprit coronary interventions were performed concurrent with primary PCI in 10% treated at experienced and high-volume PCI centers in North Americas and Western Europe at more than twice the risk (OR=>2.3, p=0.001 ):
Unadjusted and adjusted hazard ratios of 90-day mortality and 90-day death/CHF/shock (post-first-balloon-inflation) in patients with non-IRA PCI vs. IRA-only PCI.
Geographic variations were probably related to the “more ‘aggressive’ interventional environment where fee for services and procedures may influence behaviors” in Western countries.
As is so often the case, more is not always better, although a question remains why higher mortality rates only became visible after a period of time. Nonetheless, there was no evidence that more interventions improved survival, and certainly economic rewards should not play a role in clinical decision making.
This suggests perhaps that other factors, such as patient characteristics played a role as well, or is it because multiple interventions also multiply the risk of PCI failure?
- Surgical Competence, a Crisis in US Health Care?
- The Best Cardiology Blogs
- CABG Superior to PCI in long-term treatment of coronary artery disease
- CABG is Superior to PCI in Diabetics with Coronary Artery Disease
- Fatalities with Dabigatran and Warfarin Caused by Bleeding
- Interventions for Coronary Artery Disease
- Medical therapy often superior than stenting
- An approach to Hypertension Treatment In The Elderly
- Chronic anticoagulation in atrial fibrillation
- Considerations in the Treatment of Coronary Artery Disease
- Cost-Effectiveness of PCI with Drug Eluting Stents versus CABG
- Not so fast! Left-main PCI is only appropriate for minority
- Dick Cheney and modern heart failure treatment
- Five Things Physicians and Patients Should Question
- Heart health Risks of US Young People
- Stenting for stable coronary artery disease is wrong!
- Weight gains after dieting
- A Mediterranean diet is Heart Healthy
- PCI vs. CABG in Left Main CAD
- Many patients with coronary artery disease are not treated optimally
- The ABCS of Preventing Heart Attacks and Strokes
- Diastolic Dysfunction and Risk of Heart Failure
- Statin usage in low-risk patients
- Surgery for heart failure
- Cardiac Surgery Risk Analysis
- SYNTAX and CABG
- HDL and CV Risk
- VT-111 results
- Improper Cardiac Stent Implantations
- Small Coronaries
- SYNTAX 3
- PCI for STEMI should be limited to infarct-related coronary arteries
- Treatment of Chronic Kidney Disease
- Patients with 3-vessel disease should be operated!
- Patients with 3-vessel disease should undergo PCI!
- CT angiography for CAD
- COURAGE under fire
- SYNTAX analysis
- OAT Trial
- For Profit Research
- Niacin vs. Ezitimibe
- Stroke & Bypass surgery
- Elective cardiac catherization
- OMTvsPCI stable CAD
- APEX-AMI trial Analysis
- CAS vs CEA (the CREST study)
- Low Diagnostic Yield of Elective Coronary Angiography
- Statins may improve your cholesterol but not your cardiac risks
- Treatment of 3VD with/without Diabetes in Washington State
- Comments on the niacin ezitimibe study
- Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
- Medical Therapy for Stable Coronary Artery Disease
Ask Doctor T. Blog
I have been advised by my primary physician to schedule a cardiac catherization and possible stent placement procedure after having a Nuclear Stress Test with the following "Findings:
The study quality is excellent. There is no transient LV ischemic dilatation noted. The left ventricular...
I have a friend with internal defibulator. can I perform cpr and is it possible for me to get shocked if the debibulator is going off?